(Q38862471)

English

Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

0 references

anti-retroviral agent

0 references

0 references

pulmonary tuberculosis

1 reference

based on heuristic

inferred from title

Alimuddin Zumla

27

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Bruce J Kirenga

object named as

Bruce J Kirenga

2

0 references

object named as

Moses Joloba

25

0 references

21

object named as

Peter Mwaba

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

19

object named as

Nathan Kapata

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Julius J Massaga

11

object named as

Julius Massaga

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

author name string

Sayoki G Mfinanga

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Duncan M Chanda

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Beatrice Mutayoba

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Thuli Mthiyane

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Getnet Yimer

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Oliver Ezechi

7

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Cathy Connolly

8

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Vincent Kapotwe

9

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Catherine Muwonge

10

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Edford Sinkala

12

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Wanze Kohi

13

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Lucinda Lyantumba

14

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Grace Nyakoojo

15

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Henry Luwaga

16

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Basra Doulla

17

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Judith Mzyece

18

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Mahnaz Vahedi

20

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Saidi Egwaga

22

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Francis Adatu

23

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Alex Pym

24

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Roxana Rustomjee

26

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Philip Onyebujoh

28

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

publication date

5 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Lancet Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

563-571

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimum time to start antiretroviral therapy during HIV-associated opportunistic infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune restoration disease after antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Timing of initiation of antiretroviral drugs during tuberculosis therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Integration of antiretroviral therapy with tuberculosis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: results from the TIME study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of tuberculosis treatment at combination antiretroviral therapy initiation on subsequent mortality: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematological changes in women and infants exposed to an AZT-containing regimen for prevention of mother-to-child-transmission of HIV in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune reconstitution inflammatory syndrome: more answers, more questions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term care of AIDS and non-communicable diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Convergence of non-communicable and infectious diseases in low- and middle-income countries.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of early versus deferred antiretroviral therapy for HIV on survival

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970733-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(14)70733-9

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38862471&oldid=1791390896"